Yahoo has a $1.50 target listed.
Price Target Summary
Mean Target: 1.50
Median Target: 1.50
High Target: 1.50
Low Target: 1.50
No. of Brokers: 1
Now youre trying to mislead.
This company is forecast to have losses for the foreseeable future.
Profit Margin (ttm): -214.71%
Operating Margin (ttm): -120.19%
The auditors even said there is significant doubt LIVE can remain a going concern.
As long as they speak in general terms about how great a stock is?
If LIVE can pay for all that radio time, can they hire posters to hype the stock?
If so, are there guidelines in what they can and cant say?
... any sources would be appreciated.
Yeah, but if you factor in the 10 to 1 reverse split, this stock is still at $1.74
... and thats where it is destined to return to. Read the reports, its a scam.
Stock split is the perfect move to keep the hype going. It also lets the little longs feel like they now have a bunch of shares and despite there being no plan, this stock is going places. The auditors still know there is substantial doubt this company can even survive. Check the filings, they insisted it be in there.
Longs seem to not read the companies SEC submission. Sad, because they will eventually pay dearly for that.
You think they waited until market closed to make report this?
Not sure if that would make them considerate , or cunning?
... and what % had to discontinue trial because of it?
What is there about the treatment that causes this, and is there anyway to modify treatment to lesson or eliminate the problem?
I'd think it was worth $100-140, based on timeline, needing a partner, management inexperience, lack of pipeline, lawsuits, competition, etc.
This was totally expected, after the company cherry picked items for announcement and the NIH and WSJ had to "broaden" the facts with the side effects.